Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
9-10
|
| pubmed:dateCreated |
1976-11-1
|
| pubmed:language |
fre
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0003-9578
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
33
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
542-50
|
| pubmed:dateRevised |
2008-2-21
|
| pubmed:meshHeading |
pubmed-meshheading:1232922-Belgium,
pubmed-meshheading:1232922-Diphtheria Toxoid,
pubmed-meshheading:1232922-Humans,
pubmed-meshheading:1232922-Immunization Schedule,
pubmed-meshheading:1232922-Pertussis Vaccine,
pubmed-meshheading:1232922-Poliovirus Vaccine, Oral,
pubmed-meshheading:1232922-Tetanus Toxoid
|
| pubmed:articleTitle |
[Apropos of the oral trivalent and anti-poliomyelitis vaccination in Belgium. Epidemiological considerations, counter indications and practical attitudes].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|